Latest News about JNJ
Recent news which mentions JNJ
Why Emergent BioSciences Stock Is Slipping Today
February 25, 2022
From Motley Fool
Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits
February 25, 2022
From Benzinga
From MarketWatch
Got $5,000? These 2 Growth Stocks Are Down 60% From Their Highs
February 24, 2022
From Motley Fool
3 Top Stocks That Just Went on Sale
February 23, 2022
From Motley Fool
Here's How Much You Can Retire With by Investing Just $2,827 Every Year
February 21, 2022
From Motley Fool
3 Rock-Solid Stocks That Are Money Machines
February 20, 2022
From Motley Fool
Worried About Inflation? This Dividend King Is a No-Brainer Buy
February 19, 2022
Tickers
JNJ
From Motley Fool
7 Low Volatility Stocks to Buy to Escape Wild Market Swings
February 18, 2022
From InvestorPlace
Ocugen Stock Is a Fairy Tale in Need of a Happy Ending
February 18, 2022
From InvestorPlace
3 Charts That Show Just How Ridiculously Massive Pfizer's COVID-19 Revenue Will Be in 2022
February 18, 2022
From Motley Fool
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
From Benzinga
Novavax Stock Is at Risk Despite Positive Poll Results
February 16, 2022
From InvestorPlace
Short Shelf Life Of AstraZeneca's COVID-19 Shot Entangles Vaccine Rollout In Poorer Nations: Reuters
February 16, 2022
From Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
From InvestorPlace
Amgen Snags Another Approval for This Promising Cancer Drug
February 16, 2022
From Motley Fool
The Best Russell 2000 Stocks to Buy Before they Rebound
February 15, 2022
From InvestorPlace
AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial
February 15, 2022
From Benzinga
Why Are AstraZeneca Shares Trading Higher Today
February 15, 2022
From Benzinga
3 Top Biotech Stocks to Buy Right Now
February 15, 2022
From Motley Fool
These 5 tech stocks — including small caps you probably don’t know — can lead the sector’s comeback
February 14, 2022
From MarketWatch
7 Dividend Aristocrats That Could Outpace This Volatile Market
February 14, 2022
From InvestorPlace
From MarketWatch
Top Stocks Investors Are Watching This Earnings Season
February 14, 2022
From Motley Fool
Johnson & Johnson To Defend Baby-Powder Lawsuits In Court: Report
February 14, 2022
Tickers
JNJ
From Benzinga
7 Defensive Growth Stocks to Buy for February
February 14, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.